Involvement of cannabinoid type 2 (CB2) receptors in the favorable effects of sumatriptan on the random-pattern skin flap survival in rats: a novel potential target

2021 ◽  
Author(s):  
Armin Aryannejad ◽  
Nafise Noroozi ◽  
Seyed Mohammad Tavangar ◽  
Samira Ramezani ◽  
Amir Rashidian ◽  
...  

Introduction: Recent investigations have indicated the potential therapeutic role of cannabinoid type 2 (CB2) receptors in various inflammatory-related disorders. However, the role of these receptors has not been studied in skin flap models previously. In this study, we aimed to evaluate the possible involvement of CB2 receptors in the anti-inflammatory effects of sumatriptan and improvement of the random-pattern skin flap survival in rats. Methods: In a controlled experimental study, 36 male Wistar rats were randomly divided into six study groups (n = 6 per group). Two doses of sumatriptan (0.1 and 0.3 mg/kg) were administered intraperitoneally (i.p) 30 minutes before harvesting the flap tissue. In a separate group, SR144528 (a selective CB2 receptor inverse agonist) was injected before the most effective dose of sumatriptan to determine the possible involvement of CB2 receptors in its action. Histopathological examinations, the expression level of CB2 receptors (by western blot analysis), and IL-1 and TNF-α concentrations (ELISA) were explored in the skin flap samples. Results: Sumatriptan 0.3 mg/kg remarkably enhanced the skin flap survival in all macroscopic and microscopic investigations compared to the control group (P <0.001). IL-1 and TNF-α levels were significantly attenuated (P <0.001), and the expression of CB2 receptors in skin cells was amplified in rats treated with sumatriptan 0.3 mg/kg (p <0.05) compared to the control group. However, the administration of SR144528 (2 mg/kg) nullified all the protective effects of sumatriptan (0.3 mg/kg). Conclusion: We discovered that CB2 receptors play a crucial role in the favorable effects of sumatriptan on skin flap survival as a novel mechanism of action. So, targeting these receptors seems to be a dependable method in skin flap surgeries to ensure its survival and prevent tissue necrosis. Further experimental and clinical investigations are needed to ensure the safe clinical application of this method.

Author(s):  
Mohammadreza Tabary ◽  
Armin Aryannejad ◽  
Nafise Noroozi ◽  
Seyed Mohammad Tavangar ◽  
Razieh Mohammad Jafari ◽  
...  

2019 ◽  
Vol 39 (12) ◽  
pp. NP504-NP514 ◽  
Author(s):  
Yizuo Cai ◽  
Ziyou Yu ◽  
Qian Yu ◽  
Hongjie Zheng ◽  
Yuda Xu ◽  
...  

AbstractBackgroundAdipose tissue and its derivatives, including adipose-derived stem cells, stromal vascular fraction (SVF), and SVF-gel, have been utilized in the treatment of many ischemic disorders. However, the utilization of these products is limited in clinical applications by concerns related to the presence of cells in these derivatives.ObjectivesThis study aimed to isolate a cell-free fat extract (FE) from fat tissue and to evaluate its proangiogenic ability in vitro as well as its protective effects on skin flap survival in vivo.MethodsFE was isolated from human fat via a mechanical approach. The concentrations of several growth factors in the FE were determined by enzyme-linked immunosorbent assay. The proangiogenic ability of FE was evaluated utilizing assays of the proliferation, migration, and tube formation in human umbilical vein endothelial cells in vitro. The protective effects of FE on the survival of random pattern skin flaps were investigated by subcutaneous injection into rats.ResultsEnzyme-linked immunosorbent assay results revealed that FE contained proangiogenic growth factors that promoted proliferation, migration, and tube formation in human umbilical vein endothelial cells in vitro. In addition, FE reduced skin flap necrosis and increased survival, as demonstrated by macroscopic measurements and blood flow analysis. Histological analysis revealed that FE treatment increased the capillary density.ConclusionsFE is a cell-free, easy-to-prepare, and growth-factor–enriched liquid derived from human adipose tissue that possesses proangiogenic activity and improves skin flap survival by accelerating blood vessel formation. FE may be potentially used for treating ischemic disorders.


2014 ◽  
Vol 72 (1) ◽  
pp. 94-99 ◽  
Author(s):  
Shi-Ping Wang ◽  
Zhi-Yong Lan ◽  
Wei Xia ◽  
Xi Zhao ◽  
Ge-Jia Ma ◽  
...  

2019 ◽  
Vol 861 ◽  
pp. 172600
Author(s):  
Guiqian Huang ◽  
Yuting Lin ◽  
Miaojie Fang ◽  
Dingsheng Lin

2008 ◽  
Vol 69 (5) ◽  
pp. 459-465
Author(s):  
Kaan Gideroglu ◽  
Fahrettin Yilmaz ◽  
Fadullah Aksoy ◽  
Guler Bugdayci ◽  
Husamettin Cakici ◽  
...  

2018 ◽  
Author(s):  
Yizuo Cai ◽  
Ziyou Yu ◽  
Qian Yu ◽  
Hongjie Zheng ◽  
Yuda Xu ◽  
...  

1981 ◽  
Vol 89 (5) ◽  
pp. 750-752 ◽  
Author(s):  
Jeffrey B. Alperstein ◽  
Howard L. Levine ◽  
Harvey M. Tucker

The work of several investigators suggests that anemia may increase the survival length of skin flaps in the dog and the rabbit. The following experiment was designed to study the survival of standardized skin flaps of varying lengths in normocythemic, polycythemic, and anemic pigs. The pig was chosen because of the similarity of its skin to that of human skin. Twenty-nine standardized random-pattern flaps and six standardized arterial flaps were studied in pigs with varying hematocrits. A statistically significant increase was found in the survival lengths of skin flaps in the polycythemic animal as compared with the anemic one. No significant difference was found when the flap survival lengths of the normocythemic control animal were compared with those of the polycythemic animal or with those of the anemic animal. These findings suggest that relative polycythemia may allow improved flap length-survival and, in contradistinction to the findings of previous investigators, that anemia does not result in improved survival length.


Sign in / Sign up

Export Citation Format

Share Document